Continued growth, the best revenue quarter to date. More revenues about to come from the Australian Prostheses List additions, the US veterans deal, continued Asian growth and eventual Chinese revenue on top of the expansion in other areas we have seen. But the elephant in the room is the cash position, and despite rising revenues, cash burn. OSX needs cash. I don't expect it will struggle to get funding with the business so obviously moving towards positive cash flow, but be it via a major deal or a raising, the company undeniably needs a cash injection. An obvious elephant in the room.
We are all waiting for it and I am personally piling in once it announces a raise or a deal. Any discounted raising fall, if that does happen, will be short-lived.
OSX Price at posting:
20.5¢ Sentiment: Buy Disclosure: Held
